July 30, 2014

UAB begins advanced drug trial for potentially fatal pregnancy complication

Written by
The University of Alabama at Birmingham has enrolled the first patient in the United States in a Phase III clinical trial to find a treatment for preeclampsia. Preeclampsia affects a relatively small number of pregnancies – 5 to 8 percent – but its prevalence is growing.
Back to Top